Long Island University has been selected to host and test the fourth generation of the Living Heart Platform, an FDA-approved project aimed at developing and validating highly accurate personalized digital human heart models. The translational research initiative will unite leading researchers, educators, medical device developers, regulatory agencies, and practicing cardiologists on a shared mission to revolutionize cardiovascular science.
